Elevated expression of AGO is often reported in glioma, breast, hepatocellular, gastric, colon, ovarian, bladder, and prostate cancers, even though there are incidents of lower levels detected, as graphically illustrated in Figure 3. This evidence concerns the gene FBXW7 and central nervous system cancer.